These non-promotional scientific presentations were presented at the medical congresses referenced below and are intended for U.S healthcare professionals who were in attendance for the purposes of scientific exchange.

These materials may contain information outside of the FDA approved label or relate to uses that have not been approved by the FDA. Syndax does not recommend use of Syndax products in any manner other than as described in the FDA-approved Prescribing Information.

The Professional Society for Health Economics and Outcomes Research (ISPOR) Annual Meeting

Montreal, Canada May 13 - 16, 2025

Results 1

Poster Presentation | May 13, 2025

Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias with a KMT2A Translocation in the United States

Abraham I, et al.

View Material